ArticleOncogene2005
Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent.
Atsushi Shibata et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it